ALGS compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

ALGSAligos Therapeutics, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

ALGSAligos Therapeutics, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

ALGS, solidAMGN, dashed

Supply-chain overlap

Revenue flow

ALGS: latest quarter is a loss; flow not drawable.Method ›

ALGSAligos Therapeutics, Inc.

4.76· pre 4.76· delayed

Mkt cap$57.4MRevenue$28MQ2 FY26Revenue$2MFY25

AMGNAmgen Inc

460.67· pre 462.98· delayed

Pre-marketNov 4 '26delayed

Mkt cap$249.4BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

Compare

Pre-marketNov 4 '26delayed

ALGSAligos Therapeutics, Inc.

AMGNAmgen Inc

4.76pre 4.76delayed

Price

460.67pre 462.98delayed

$57.4M

Mkt cap

$249.4B

Q2 FY26$28M

Revenue

$10.1BQ2 FY26

FY25$2M

Revenue

$36.8BFY25

ALGS4.76vsAMGN460.67Pre-marketNov 4 '26delayed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ALGS 15

MRKMerck Sharp & Dohmecustomer

ADCTADC Therapeutics (ADCT)customer

—Emory Universityunlistedsupplier

—Rega Institute at Katholieke Universiteit Leuven (KU Leuven)unlistedsupplier

11 more · ALGS chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›